Incremental Consolidation in Pharmaceuticals
The drug market isn't consolidating much, despite the mergers which have taken place, according to data from PMSI International. For individual companies, the market share growth available can only practically come through acquisition, not pipeline-driven growth.
You may also be interested in...
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.